Caterpillar's record-breaking Q3 driven by strong demand for power generation equipment used in AI data centers, offsetting construction slowdowns and tariff headwinds.
Texas teams open 2025-26 basketball season with key matchups and roster changes.
Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.
Caterpillar's record-breaking Q3 driven by strong demand for power generation equipment used in AI data centers, offsetting construction slowdowns and tariff headwinds.
Texas teams open 2025-26 basketball season with key matchups and roster changes.
Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.